跳至主要内容
临床试验/EUCTR2015-000168-32-NL
EUCTR2015-000168-32-NL进行中(未招募)1 期

Mesenchymal stem cells for Angiogenesis and Neovascularization in digital Ulcers of Systemic sclerosis - MANUS Trial

niversity Medical Center Utrecht0 个研究点开始时间: 2015年7月9日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age >18 years
  • - Established diagnosis of SSc according to criteria of the American College of Rheumatology (2013)
  • - At least one active digital ulcer (painful area, >2 mm in diameter with visible depth and loss of dermis) refractory to intravenous prostacyclins
  • ------------‘Refractory to prostacyclins’ is defined as
  • ?-Worsening of ulcer(s) at 1 month after prostacyclins iv
  • ?-No improvement of ulcer(s) at 2 months after prostacyclins iv, as judged by the referring physician
  • ?-Recurrence of exactly the same ulcer(s) (same location) at 3 months after prostacyclins iv
  • - Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Ulcer with underlying calcinosis (ruled out by X-ray prior to referral)
  • -History of neoplasm or malignancy in the past 10 years
  • - Pregnancy or unwillingness to use adequate contraception during study
  • - Serious known concomitant disease with life expectancy <1 year
  • - Uncontrolled hypertension
  • - Uncontrolled acute or chronic infection
  • - Follow-up impossible.

研究者

相似试验